Ticker
TRVICompany Name
TREVI THERAPEUTICS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQDate | Debt to Equity Ratio | Shareholders Equity | Total Liabilities |
---|---|---|---|
6/30/2025 | 0.05 | $ 198.49M | $ 9.85M |
3/31/2025 | 0.08 | $ 99.46M | $ 7.55M |
12/31/2024 | 0.11 | $ 99.64M | $ 11.26M |
9/30/2024 | 0.17 | $ 58.97M | $ 9.94M |
6/30/2024 | 0.12 | $ 66.17M | $ 7.64M |
3/31/2024 | 0.09 | $ 72.33M | $ 6.22M |
12/31/2023 | 0.08 | $ 82.55M | $ 6.86M |
9/30/2023 | 0.07 | $ 89.61M | $ 6.29M |
6/30/2023 | 0.06 | $ 95.07M | $ 5.9M |
3/31/2023 | 0.14 | $ 101.73M | $ 14.47M |
Liabilities / Equity
(=) D/E
D/E for TREVI THERAPEUTICS INC is calculated as follows: Liabilities [ $ 20.26M ] / Equity [ $ 35.62M ]
(=) D/E [ 0.57 ]
Minimum
Jun 30, 2025
Maximum
Mar 31, 2022
Average
Median
filtered constituents | 3.3K |
---|---|
min | 0 |
max | 6.03 |
average | 1.39 |
median | 0.98 |
std | 1.31 |